Get started
Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ACXP chart


Full chart

ACXP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪13.94 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.0958 USD
Net income (FY)
‪−14.58 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪14.49 M‬
Beta (1Y)
−0.04

Employees


Employees (FY)
4
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.64 M‬ USD

About Acurx Pharmaceuticals, Inc.


Sector
Health Technology
CEO
David P. Luci
Headquarters
New York
Website
acurxpharma.com
Founded
2017
FIGI
BBG01184DNJ4
Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ACXP news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ACXP is 0.8250 USD — it has increased by 8.77% in the past 24 hours. Watch Acurx Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Acurx Pharmaceuticals, Inc. stocks are traded under the ticker ACXP.
ACXP stock has fallen by −6.99% compared to the previous week, the month change is a −52.31% fall, over the last year Acurx Pharmaceuticals, Inc. has showed a −76.83% decrease.
We've gathered analysts' opinions on Acurx Pharmaceuticals, Inc. future price: according to them, ACXP price has a max estimate of 12.00 USD and a min estimate of 10.00 USD. Watch ACXP chart and read a more detailed Acurx Pharmaceuticals, Inc. stock forecast: see what analysts think of Acurx Pharmaceuticals, Inc. and suggest that you do with its stocks.
ACXP reached its all-time high on Oct 12, 2023 with the price of 8.8200 USD, and its all-time low was 0.7200 USD and was reached on Dec 4, 2024. View more price dynamics on ACXP chart.
See other stocks reaching their highest and lowest prices.
ACXP stock is 10.06% volatile and has beta coefficient of −0.04. Track Acurx Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Acurx Pharmaceuticals, Inc. there?
Today Acurx Pharmaceuticals, Inc. has the market capitalization of ‪13.94 M‬, it has decreased by −2.15% over the last week.
Yes, you can track Acurx Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Acurx Pharmaceuticals, Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ACXP earnings for the last quarter are −0.17 USD per share, whereas the estimation was −0.14 USD resulting in a −17.24% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about Acurx Pharmaceuticals, Inc. earnings.
ACXP net income for the last quarter is ‪−2.82 M‬ USD, while the quarter before that showed ‪−4.12 M‬ USD of net income which accounts for 31.54% change. Track more Acurx Pharmaceuticals, Inc. financial stats to get the full picture.
No, ACXP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 4.00 employees. See our rating of the largest employees — is Acurx Pharmaceuticals, Inc. on this list?
Like other stocks, ACXP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Acurx Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Acurx Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Acurx Pharmaceuticals, Inc. stock shows the strong sell signal. See more of Acurx Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.